Stockscreener 앱 받기
43.53
1.61%
0.69
시간 외 거래:
43.43
-0.10
-0.23%
전일 마감가:
$42.84
열려 있는:
$42.88
하루 거래량:
745.34K
Relative Volume:
0.78
시가총액:
$3.44B
수익:
$399.58M
순이익/손실:
$-54.04M
주가수익비율:
-58.04
EPS:
-0.75
순현금흐름:
$40.13M
1주 성능:
-1.87%
1개월 성능:
+10.62%
6개월 성능:
+64.64%
1년 성능:
+0.72%
1일 변동 폭
$42.36
$43.69
1주일 범위
$41.55
$45.16
52주 변동 폭
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
명칭
Veracyte Inc
전화
(650) 243-6300
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
VCYT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
43.53 | 3.39B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
575.91 | 215.01B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
228.53 | 159.87B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
700.55 | 56.23B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
140.60 | 39.54B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
223.63 | 37.85B | 15.90B | 1.28B | 2.21B | 7.2842 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Underweight |
| 2025-10-20 | 개시 | Canaccord Genuity | Hold |
| 2025-03-20 | 개시 | Craig Hallum | Buy |
| 2024-12-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-10-16 | 개시 | UBS | Buy |
| 2024-10-10 | 개시 | Guggenheim | Buy |
| 2024-02-23 | 재확인 | Needham | Buy |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-11-18 | 재개 | Goldman | Buy |
| 2021-06-15 | 개시 | Raymond James | Outperform |
| 2021-02-18 | 재개 | Needham | Buy |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 개시 | Morgan Stanley | Underweight |
| 2019-07-31 | 개시 | Lake Street | Buy |
| 2019-07-02 | 개시 | Needham | Buy |
| 2018-11-29 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-10-31 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-07 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-11-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 재개 | BTIG Research | Buy |
| 2016-11-14 | 재개 | Leerink Partners | Outperform |
| 2015-12-18 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-11 | 재확인 | Leerink Partners | Outperform |
| 2013-11-26 | 개시 | William Blair | Outperform |
모두보기
Veracyte Inc 주식(VCYT)의 최신 뉴스
Veracyte, Inc. $VCYT Shares Sold by Nikko Asset Management Americas Inc. - MarketBeat
Veracyte (NASDAQ:VCYT) Stock Rating Lowered by Wall Street Zen - MarketBeat
First Trust Advisors LP Raises Holdings in Veracyte, Inc. $VCYT - MarketBeat
PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor - sharewise.com
Next Century Growth Investors LLC Lowers Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
JPMorgan Chase & Co. Buys 243,111 Shares of Veracyte, Inc. $VCYT - MarketBeat
Eastham (Veracyte director) sells $908k in VCYT stock By Investing.com - Investing.com Canada
Insider Selling: Veracyte (NASDAQ:VCYT) Director Sells 20,000 Shares of Stock - MarketBeat
Eastham (Veracyte director) sells $908k in VCYT stock - Investing.com
Veracyte Insider Sold Shares Worth $908,923, According to a Recent SEC Filing - marketscreener.com
Beat the Market the Zacks Way: Veracyte, Las Vegas Sands, 3M in Focus - Yahoo Finance
Prudential Financial Inc. Has $1 Million Position in Veracyte, Inc. $VCYT - MarketBeat
Investment Report: How analysts rate Veracyte Inc stock todayJuly 2025 Gainers & AI Driven Price Predictions - moha.gov.vn
Veracyte (NASDAQ:VCYT) Shares Down 4.5% on Insider Selling - MarketBeat
Insider Selling: Veracyte (NASDAQ:VCYT) Insider Sells 1,278 Shares of Stock - MarketBeat
Veracyte (NASDAQ:VCYT) CEO Marc Stapley Sells 7,668 Shares - MarketBeat
Annie Mcguire Sells 1,422 Shares of Veracyte (NASDAQ:VCYT) Stock - MarketBeat
Insider Selling: Veracyte (NASDAQ:VCYT) CFO Sells 13,278 Shares of Stock - MarketBeat
Will Veracyte Inc. (12V) stock profit from fiscal stimulusVolume Spike & Precise Buy Zone Identification - Newser
Can Veracyte Inc. (12V) stock sustain breakout momentumQuarterly Profit Summary & Low Drawdown Trading Techniques - Newser
Veracyte (VCYT): CFO Chambers sells $621,955 in shares By Investing.com - Investing.com Australia
Veracyte NASDAQ:VCYT CEO Stapley sells $361k in shares By Investing.com - Investing.com UK
Veracyte VCYT: chief commercial officer Leite sells $61k in stock - Investing.com Nigeria
Annie Mcguire, Veracyte SVP, sold $67k in VCYT stock By Investing.com - Investing.com Canada
Annie Mcguire, Veracyte SVP, sold $67k in VCYT stock - Investing.com
Veracyte (VCYT): CFO Chambers sells $621,955 in shares - Investing.com India
Will Veracyte Inc. (12V) stock benefit from infrastructure billJuly 2025 Update & Real-Time Chart Pattern Alerts - Newser
Panagora Asset Management Inc. Sells 41,108 Shares of Veracyte, Inc. $VCYT - MarketBeat
Can Veracyte Inc. (12V) stock sustain revenue momentum2025 Price Action Summary & Safe Entry Zone Tips - Newser
Capital Fund Management S.A. Takes Position in Veracyte, Inc. $VCYT - MarketBeat
Is Veracyte Inc. (12V) stock resilient in recession scenariosJuly 2025 Retail & Daily Chart Pattern Signals - Newser
Is Veracyte Inc. (12V) stock nearing a technical breakout2025 Fundamental Recap & Weekly High Return Forecasts - Newser
Veracyte NASDAQ:VCYT CEO Stapley sells $361k in shares - Investing.com
Veracyte, Inc. (VCYT) Stock Forecasts - Yahoo Finance
Loomis Sayles & Co. L P Trims Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte assumed with an Underweight at Morgan Stanley - MSN
Why Veracyte (VCYT) is a Top Growth Stock for the Long-Term - sharewise.com
Analyst Tejas Savant Raises Price Target for Veracyte (VCYT) to $48.00 | VCYT Stock News - GuruFocus
Virtus Advisers LLC Sells 31,958 Shares of Veracyte, Inc. $VCYT - MarketBeat
Morgan Stanley Raises Price Target on Veracyte to $48 From $40, Keeps Underweight Rating - marketscreener.com
Will Veracyte Inc. stock benefit from AI adoptionWeekly Volume Report & Entry and Exit Point Strategies - Newser
Is Veracyte Inc. stock safe for conservative investorsJuly 2025 Setups & Free Accurate Trade Setup Notifications - Newser
Why analysts upgrade Veracyte Inc. stockJuly 2025 Selloffs & Verified Entry Point Detection - Newser
Veracyte Inc (VCYT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Veracyte Inc 주식 (VCYT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| EASTHAM KARIN | Director |
Dec 05 '25 |
Sale |
45.45 |
20,000 |
908,923 |
13,554 |
0.04%
0.32%
자본화:
|
볼륨(24시간):